Publication | Closed Access

Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women

ObesityMetabolic SyndromeInsulin ResistanceWeight LossHealth SciencesMetabolic DisorderMedicineInsulin ManagementDiabetesObesity ManagementMetabolic ComplicationPharmacotherapyEndocrinologyPharmacologyShort Term Monotherapy